Post-operative blood salvage in patient blood management: Is it really cost-effective and safe?

Blood Transfusion

Volumn 11, Issue 2, 2013, Pages 175-177

  Liumbruno, Giancarlo M ^a   Grazzini, Gioia ^a   Rafanelli, Daniela ^b  

^a SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^b AUSL 3   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

BLOOD; BLOOD CONSERVATION; BLOOD SALVAGE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; PATIENT SAFETY; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; TOTAL KNEE REPLACEMENT; UNITED STATES;

EID: 84876902058     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0001-13     Document Type: Editorial

References (35)

1. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010;24:77-124.
2. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753-65.
3. Drackley A, Newbold KB, Paez A, Heddle N. Forecasting Ontario's blood supply and demand. Transfusion 2012;52:366-74.
4. Seifried E, Klueter H, Weidmann C, et al. How much blood is needed? Vox Sang 2011;100:10-21.
5. Desalvo F, Verlicchi F, Tomasini I. An estimate of future transfusion needs in the province of Ravenna made on the basis of Italian national statistics and past consumption. Blood Transfus 2011;9:413-8.
6. Leahy MF, Mukhtar SA. From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice. Intern Med J 2012;42:332-8.
7. Society for the Advancement of Blood Management (SABM). Glossary. Available at: http://www.sabm.org/glossary/patientbloodmanagement. Accessed on 31/12/2012.
8. Goodnough LT, Shander A. Special article: current status of pharmacologic therapies in patient blood management. Anesth Analg 2013;116:15-34.
9. Hofmann A, Farmer S, Shander A. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. Oncologist 2011;16(Suppl 3):3-11.
10. Sixty-Third World Health Assembly, WHA 63.12 (resolution). Availability, safety and quality of blood products, 21 May 2010, Geneva, Switzerland. Available at: http://apps.who.int/gb/ebwha/pdf-files/WHA63/A63-R12-en.pdf. Accessed on 31/12/2012.
11. Frellick M. Better blood management could be a boon for hospitals. Hosp Health Netw 2012;86:46-8, 1.
12. Shander A, Javidroozi M. Strategies to reduce the use of blood products: a US perspective. Curr Opin Anaesthesiol 2012;25:50-8.
13. De Leon EM, Szallasi A. "Transfusion indication RBC (PBM-02) ": gap analysis of a Joint Commission Patient Blood Management Performance Measure at a community hospital. Blood Transfus DOI: 10.2450/2012.0088-12.
14. Hofmann A, Farmer S, Towler SC. Strategies to preempt and reduce the use of blood products: an Australian perspective. Curr Opin Anaesthesiol 2012;25:66-73.
15. Theusinger OM, Felix C, Spahn DR. Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol 2012;25:59-65.
16. Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth 2012;109:55-68.
17. Goodnough LT, Shander A. Patient blood management. Anesthesiology 2012;116:1367-76.
18. Muñoz M, Ariza D, Campos A, et al. The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1, 093 consecutive procedures. Blood Transfus 2013;11:260-71.
19. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012;4:CD002042.
20. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;157:49-58.
21. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453-62.
22. Strauss RG. The value of postoperative red cell transfusions is unclear. Transfusion 1993;33:622-3. (Pubitemid 23210803)
23. Liumbruno GM, Waters JH. Unwashed shed blood: should we transfuse it? Blood Transfus 2011;9:241-5.
24. National Blood Authority. Patient Blood Management Guideline: Module 2 - Perioperative. Canberra, Australia: National Blood Authority; 2012. Available at: http://www.nba.gov. au/guidelines/module2/po-v1a.pdf. Accessed on 29/12/2012.
25. Liumbruno GM, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology Working Party. Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period. Blood Transfus 2011;9:320-35.
26. Taylor C (Ed.), Cohen H, Mold D, Jones H, et al, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2009 Annual SHOT Report (2010). Available at: http://www.shotuk.org/wp-content/uploads/2010/07/SHOT2009. pdf. Accessed on 12/12/2012.
27. Bolton-Maggs PHB (Editor), Cohen H, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report (2012). Available at: http://www.shotuk.org/wp-content/uploads/2012/07/SHOT-ANNUALREPORT- FinalWebVersionBookmarked-2012-06-22.pdf. Accessed on 12/12/2012.
28. Società Italiana di Medicina Trasfusionale e Immunoematologia (SIMTI). Standards of Transfusion Medicine. 2nd ed,. Milan, Italy: Edizioni SIMTI; 2010. Available at: http://www.simti. it/pdf/Standard-EN-protetto.pdf. Accessed on 12/12/2012.
29. Kroch E, Champion RW, DeVore SD, et al. Measuring Progress toward Accountable Care. New York, USA: The Commonwealth Fund; December 2012. Available at: http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/ 2012/Dec/1652-Kroch-Measuring-Progress-web-1212.pdf. Accessed on 29/12/2012.
30. Schulman S. Pharmacologic tools to reduce bleeding in surgery. Hematology Am Soc Hematol Educ Program 2012;2012:517-21.
31. Bruce W, Campbell D, Daly D, Isbister J. Practical recommendations for patient blood management and the reduction of perioperative transfusion in joint replacement surgery. ANZ J Surg 2012; DOI: 10.1111/ans.12000.
32. Liumbruno GM, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 2011;9:189-217.
33. Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012;94:1153-9.
34. Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2012;20:1742-52.
35. Alshryda S, Sarda P, Sukeik M, et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011;93:1577-85.